Both, gestational diabetes mellitus (GDM) and pre-gestational diabetes mellitus (PGDM) have been demonstrated to contribute to changes in the expression and activity of glucose transporters in the placenta, with insulin therapy as a possible modulatory factor [8, 14–17]. The gene discussed is INS; the disease is gestational diabetes.